Fresenius Medical Care Corporation

Fresenius Medical Care Corporation is a global healthcare company whose core business includes the development and manufacturing of medical devices, pharmaceuticals, and dialysis products. As documented by Cruelty Free Investors, the company conducts animal testing as part of its product development and regulatory compliance processes. Its own Global Supplier Code of Conduct acknowledges the use of animal trials, advising that they "should be avoided as far as possible," while its Code of Conduct for Business Partners encourages the "replace, reduce, and refine" principles for such testing.

The company's Sustainability Statement for 2024 references animal welfare commitments within the context of "Ethical Conduct in Clinical Research," indicating that animal testing remains an active part of its operational framework. While Fresenius expresses a commitment to minimizing animal use, its inclusion on the Cruelty Free Investing exclusion list confirms that animal testing is a current and material component of its business activities.